We are live on
!
Find out more
BMS
Brummer Multi-Strategy Portfolio holdings
AUM
$1.22M
1-Year Est. Return
46.51%
This Fund
S&P 500
This Quarter
Est. Return
-7.48%
1 Year Est. Return
+46.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24M
AUM Growth
+$7.48M
(+45%)
Cap. Flow
+$9.68M
Cap. Flow
% of AUM
40.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
3
Increased
4
Reduced
1
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRE Group
CBRE
|
+$7.57M |
| 2 |
Agree Realty
ADC
|
+$6.6M |
| 3 |
W.P. Carey
WPC
|
+$2M |
| 4 |
Arvinas
ARVN
|
+$1.47M |
| 5 |
Maravai LifeSciences
MRVI
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmark Group
NMRK
|
+$3.48M |
| 2 |
Cigna
CI
|
+$3.25M |
| 3 |
IQVIA
IQV
|
+$1.84M |
| 4 |
Becton Dickinson
BDX
|
+$1M |
| 5 |
SLNO
Soleno Therapeutics
SLNO
|
+$405K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 63.5% |
| 2 | Healthcare | 35.99% |
| 3 | Materials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CBRE Group
CBRE
$40.4B
| $6.75M | 28.09% |
+49,817
| New | +$7.57M |
|
|
2
Agree Realty
ADC
$8.46B
| $6.57M | 27.34% |
+87,127
| New | +$6.6M |
|
|
3
Arvinas
ARVN
$542M
| $3.02M | 12.58% |
285,076
+118,734
| +71% | +$1.47M |
|
|
ABVX
4
Abivax
ABVX
$9.17B
| $2.5M | 10.4% |
22,428
+8,053
| +56% | +$953K |
|
|
5
Maravai LifeSciences
MRVI
$1.04B
| $2.15M | 8.95% |
759,743
+302,036
| +66% | +$1.02M |
|
|
6
W.P. Carey
WPC
$15.1B
| $1.94M | 8.07% |
+28,508
| New | +$2M |
|
|
ATAI
7
DELISTED
AtaiBeckley Inc
ATAI
| $975K | 4.06% |
275,409
+40,494
| +17% | +$152K |
|
|
GRML
8
Greenland Mines Ltd
GRML
$9.05M
| $122K | 0.51% |
7,401
-4,734
| -39% | -$81.4K |
|
|
9
Becton Dickinson
BDX
$49.3B
| – | – |
-5,176
| Closed | -$1M |
|
|
10
Cigna
CI
$72.7B
| – | – |
-11,818
| Closed | -$3.25M |
|
11
Foghorn Therapeutics
FHTX
$246M
| – | – |
-4,708
| Closed | -$25.4K |
|
|
12
IQVIA
IQV
$43.9B
| – | – |
-8,183
| Closed | -$1.84M |
|
|
13
Newmark Group
NMRK
$2.53B
| – | – |
-200,493
| Closed | -$3.48M |
|
|
SLNO
14
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-8,741
| Closed | -$405K |
|
Similar funds
DF
VS
AI
EW
FLC
CA
HGCK
PCM
Brummer Multi-Strategy's Q1 2026 Portfolio in Review
As of Q1 2026, Brummer Multi-Strategy held 14 positions worth $24M, up 45% from $16.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Brummer Multi-Strategy deployed $9.68M of net new capital in Q1 2026, opening 3 new positions and adding to 4 existing holdings. Its largest new stake was CBRE Group: 49,817 shares worth $6.75M.
By sector, the portfolio is most concentrated in Real Estate at 64% of assets, up from 21% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Greenland Mines Ltd, an estimated $81.4K trimmed.
- Brummer Multi-Strategy's largest Q1 2026 buy was CBRE Group: 49,817 shares worth $6.75M.
- Brummer Multi-Strategy added most to Arvinas in Q1 2026, an estimated $1.47M increase.
- Brummer Multi-Strategy's biggest Q1 2026 reduction was Greenland Mines Ltd, cutting an estimated $81.4K.
- Brummer Multi-Strategy fully exited Newmark Group in Q1 2026, selling an estimated $3.48M.
- Brummer Multi-Strategy's ten largest holdings make up 100% of its $24M portfolio in Q1 2026.
- Brummer Multi-Strategy opened 3 new positions and closed 6 in Q1 2026.
- Brummer Multi-Strategy's portfolio value rose 45% quarter-over-quarter to $24M.
Based on Brummer Multi-Strategy's 13F filing for Q1 2026, filed 6 May 2026.